<DOC>
	<DOCNO>NCT03075969</DOCNO>
	<brief_summary>The objective study test scale structure , reliability , validity responsiveness change QLQ-CML24 conjuction QLQ-C30 patient diagnose CML , investigate longitudinal relationship satisfaction information provision QoL outcome .</brief_summary>
	<brief_title>Phase IV EORTC Quality Life Module Patients With Chronic Myeloid Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<criteria>Above 18 year age . Patient confirm diagnosis Philadelphia chromosome positive and/or BCRABL positive chronic myeloid leukemia ( CML ) . Written informed consent . Patients enrol investigational drugtrials type clinical trial also eligible . Patients psychiatric condition major cognitive impairment ( evaluated treat physician ) would hinder completion selfreported healthrelated QoL questionnaire . Patients unable speak read language questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic myeloid leukemia ; quality life</keyword>
</DOC>